Illustratively, hydrazones derived from 4-hydroxybenzohydrazide have been studied as a new class of dual inhibitors of thymidine phosphorylase and cancer cell proliferation, which deserves to be further investigated for anti-cancer drug development [19], as well as indole-based acetohydrazide inhibitors of this enzyme [20]. The gene discussed is TYMP; the disease is cancer.